Lung function decline and variable airway inflammatory pattern: Longitudinal analysis of severe asthma

Lung function decline and variable airway inflammatory pattern: Longitudinal analysis of severe asthma

Zobrazit další vydání (1)

Background Eosinophilic airway inflammation measured by using induced sputum is an important treatment stratification tool in patients with severe asthma. In addition, sputum eosinophilia has been shown to be associated with severe exacerbations and airflow limitation. Objectives We sought to identi...

Podrobná bibliografie
Hlavní autoři:	Newby, C, Agbetile, J, Hargadon, B, Monteiro, W, Green, R, Pavord, I, Brightling, C, Siddiqui, S
Médium:	Journal article
Jazyk:	English
Vydáno:	Mosby Inc. 2014

Podobné jednotky

Lung function decline and variable airway inflammatory pattern: longitudinal analysis of severe asthma.
Autor: Newby, C, a další
Vydáno: (2014)

Temporal assessment of airway remodeling in severe asthma using quantitative computed tomography.
Autor: Gupta, S, a další
Vydáno: (2015)

Eosinophils in asthma and airway hyperresponsiveness.
Autor: Brightling, C, a další
Vydáno: (2004)

IgE sensitization to Aspergillus fumigatus is associated with reduced lung function in asthma.
Autor: Fairs, A, a další
Vydáno: (2010)

Multiple inflammatory hits and the pathogenesis of severe airway disease.
Autor: Pavord, I, a další
Vydáno: (2006)

The significance of eosinophilic airway inflammation in asthma
Autor: Pavord, I, a další
Vydáno: (2002)

Association between neutrophilic airway inflammation and airflow limitation in adults with asthma.
Autor: Shaw, D, a další
Vydáno: (2007)

Comparison of asthma treatment given in addition to inhaled corticosteroids on airway inflammation and responsiveness.
Autor: Green, R, a další
Vydáno: (2006)

Exacerbations of severe asthma in patients treated with mepolizumab
Autor: Shrimanker, R, a další
Vydáno: (2018)

New insights into the relationship between airway inflammation and asthma.
Autor: Wardlaw, A, a další
Vydáno: (2002)

Alveolar nitric oxide in adults with asthma: evidence of distal lung inflammation in refractory asthma.
Autor: Berry, M, a další
Vydáno: (2005)

Location, location, location: microlocalisation of inflammatory cells and airway dysfunction.
Autor: Brightling, C, a další
Vydáno: (2004)

Comparison of airway immunopathology of eosinophilic bronchitis and asthma.
Autor: Brightling, C, a další
Vydáno: (2003)

Chapter 11. Mast cell localization within the airway smooth muscle: Relationship to airway hyperresponsiveness and other asthma phenotypes
Autor: Wardlaw, A, a další
Vydáno: (2004)

Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: A 12-month follow-up analysis
Autor: Haldar, P, a další
Vydáno: (2014)

Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: a 12-month follow-up analysis.
Autor: Haldar, P, a další
Vydáno: (2014)

Mast-cell infiltration of airway smooth muscle in asthma.
Autor: Brightling, C, a další
Vydáno: (2002)

Effectiveness of voriconazole in the treatment of Aspergillus fumigatus-associated asthma (EVITA3 study).
Autor: Agbetile, J, a další
Vydáno: (2014)

Effectiveness of voriconazole in the treatment of Aspergillus fumigatus-associated asthma (EVITA3 study)
Autor: Agbetile, J, a další
Vydáno: (2014)

Variability in airway inflammation, symptoms, lung function and reliever use in asthma: anti-inflammatory reliever hypothesis and STIFLE study design
Autor: Tim Harrison, a další
Vydáno: (2020-06-01)

The role of oral methotrexate as a steroid sparing agent in refractory eosinophilic asthma.
Autor: Bilocca, D, a další
Vydáno: (2017)

The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma.
Autor: Berry, M, a další
Vydáno: (2005)

Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: A 12-month follow-up analysis
Autor: Haldar, P, a další
Vydáno: (2014)

Mepolizumab and exacerbations of refractory eosinophilic asthma.
Autor: Haldar, P, a další
Vydáno: (2009)

Isolation of filamentous fungi from sputum in asthma is associated with reduced post-bronchodilator FEV1.
Autor: Agbetile, J, a další
Vydáno: (2012)

Eosinophil protein in airway macrophages: a novel biomarker of eosinophilic inflammation in patients with asthma.
Autor: Kulkarni, N, a další
Vydáno: (2010)

Eosinophils in Asthma and Airway Hyperresponsiveness [3] (multiple letters)
Autor: Brightling, C, a další
Vydáno: (2004)

Biomarkers predicting response to corticosteroid therapy in asthma.
Autor: Brightling, C, a další
Vydáno: (2005)

The peripheral blood eosinophil count as a biomarker of eosinophilic airway inflammation in patients with asthma and COPD. Experience from a single centre
Autor: Shrimanker, R, a další
Vydáno: (2017)

Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.
Autor: Green, R, a další
Vydáno: (2002)

Qualitative analysis of high-resolution CT scans in severe asthma.
Autor: Gupta, S, a další
Vydáno: (2009)

Sputum mediator profiling and relationship to airway wall geometry imaging in severe asthma
Autor: Desai Dhananjay, a další
Vydáno: (2013-02-01)

Asthma control, airway responsiveness and airway inflammation.
Autor: Pavord, I
Vydáno: (2009)

Body mass and fat mass in refractory asthma: an observational 1 year follow-up study.
Autor: Bafadhel, M, a další
Vydáno: (2010)

The upper and lower airway microbiome in severe asthma
Autor: Jabeen, M, a další
Vydáno: (2022)

Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial.
Autor: Siva, R, a další
Vydáno: (2007)

A cross-sectional study of patterns of airway dysfunction, symptoms and morbidity in primary care asthma.
Autor: Shaw, D, a další
Vydáno: (2012)

Quantitative analysis of high-resolution computed tomography scans in severe asthma subphenotypes.
Autor: Gupta, S, a další
Vydáno: (2010)

Stability of inflammatory phenotypes in asthma.
Autor: Green, R, a další
Vydáno: (2012)

Long-term effect of dupilumab on prevention of lung function decline in patients with uncontrolled moderate-to-severe asthma: ATLAS trial design
Autor: Lucia De Prado Gomez, a další
Vydáno: (2023-03-01)